Form 4 for BHC Bausch Health Companies Inc.
Accepted 2024-08-21 00:00:00 ET · period of report 2024-08-19 · accession 0001127602-24-022700 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-21 | 2024-08-19 | BHC | Charhon Jean-Jacques | EVP, CFO | A - Grant | $0.00 | +298.8K | 298.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2024-08-19 | A | A | 298,838 | $0.00 | 298,838 | D | — | — | (F1) Represents the award of restricted share units ("RSUs") which will vest in three equal installments. The first installment will vest on the first anniversary of the grant date, the second installment will vest on February 28, 2026, and the third installment will vest on February 28, 2027, subject generally to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. |